SCHEMBL29343013

SCHEMBL29343013

C=CCOc1cccc(F)c1Cc1c[nH]nc1C(=O)OCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EED O75530 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ GABRA4 P48169 1/20 0.36
▸ GABRE P78334 1/20 0.36
▸ GABRA6 Q16445 1/20 0.36
▸ GABRG1 Q8N1C3 1/20 0.36
▸ GABRG3 Q99928 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29342737 0.84 ALDH1A1 (0.40) MAPTKMT2AMEN1GABRPGABRD
SCHEMBL29343015 0.80 KMT2A (0.36) EEDMAPTKMT2AMEN1GABRP
SCHEMBL29339985 0.80 MAPT (0.35) MAPTALDH1A1KDM4EGAAHPGD
SCHEMBL29343007 0.72 IL2 (0.32) EEDKMT2AMEN1SUZ12EZH2
SCHEMBL27163469 0.70 KDM4E (0.45) EEDMAPTKMT2AMEN1ALDH1A1
SCHEMBL21736938 0.70 ADRA2A (0.42) MAPTALDH1A1KDM4EHPGDTSHR
SCHEMBL948640 0.69 SMN1; SMN2 (0.59) MAPTKMT2AMEN1GABRA1GABRB1
SCHEMBL946588 0.68 KDM4E (0.47) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL1431096 0.67 KDM4E (0.46) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL29342683 0.67 KDM4E (0.46) MAPTKMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 EED 4841/4885MAPT 506/4885KMT2A 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback